Supplementary Table S2 from Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies
Authors:
- Jayastu SenapatiJSJayastu Senapati
- Warren C. FiskusWFWarren C. Fiskus
- Naval DaverNaval Daver
- Nathaniel R. WilsonNWNathaniel R. Wilson
- Farhad RavandiFarhad Ravandi
- Guillermo Garcia-ManeroGGGuillermo Garcia-Manero
- Tapan KadiaTKTapan Kadia
- Courtney D. DiNardoCDCourtney D. DiNardo
- Elias JabbourEJElias Jabbour
- Jan BurgerJBJan Burger
- Nicholas J. ShortNicholas J. Short
- Yesid AlvaradoYAYesid Alvarado
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)